Literature DB >> 28089286

Historical perspective on the medical use of cannabis for epilepsy: Ancient times to the 1980s.

Daniel Friedman1, Joseph I Sirven2.   

Abstract

There has been a dramatic surge in the interest of utilizing cannabis for epilepsy treatment in the US. Yet, access to cannabis for research and therapy is mired in conflicting regulatory policies and shifting public opinion. Understanding the current state of affairs in the medical cannabis debate requires an examination of the history of medical cannabis use. From ancient Chinese pharmacopeias to the current Phase III trials of pharmaceutical grade cannabidiol, this review covers the time span of cannabis use for epilepsy therapy so as to better assess the issues surrounding the modern medical opinion of cannabis use. This article is part of a Special Issue titled Cannabinoids and Epilepsy.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cannabinoids; Cannabis; Epilepsy; History; Seizure

Mesh:

Substances:

Year:  2017        PMID: 28089286     DOI: 10.1016/j.yebeh.2016.11.033

Source DB:  PubMed          Journal:  Epilepsy Behav        ISSN: 1525-5050            Impact factor:   2.937


  14 in total

Review 1.  Therapeutic use of medicinal cannabis in difficult to manage epilepsy.

Authors:  John A Lawson; Ingrid E Scheffer
Journal:  Br J Clin Pharmacol       Date:  2018-09-05       Impact factor: 4.335

Review 2.  Status and Impacts of Recreational and Medicinal Cannabis Policies in Africa: A Systematic Review and Thematic Analysis of Published and "Gray" Literature.

Authors:  Chenai Kitchen; John Alimamy Kabba; Yu Fang
Journal:  Cannabis Cannabinoid Res       Date:  2022-01-05

Review 3.  Medical Cannabis for Older Patients.

Authors:  Amir Minerbi; Winfried Häuser; Mary-Ann Fitzcharles
Journal:  Drugs Aging       Date:  2019-01       Impact factor: 3.923

Review 4.  The Role of Cannabidiol in Neurological Disorders.

Authors:  Sirichai Chayasirisobhon
Journal:  Perm J       Date:  2021-05

5.  Modulation of Recombinant Human T-Type Calcium Channels by Δ9-Tetrahydrocannabinolic Acid In Vitro.

Authors:  Somayeh Mirlohi; Chris Bladen; Marina Santiago; Mark Connor
Journal:  Cannabis Cannabinoid Res       Date:  2021-01-21

6.  Cannabigerolic acid, a major biosynthetic precursor molecule in cannabis, exhibits divergent effects on seizures in mouse models of epilepsy.

Authors:  Lyndsey L Anderson; Marika Heblinski; Nathan L Absalom; Nicole A Hawkins; Michael T Bowen; Melissa J Benson; Fan Zhang; Dilara Bahceci; Peter T Doohan; Mary Chebib; Iain S McGregor; Jennifer A Kearney; Jonathon C Arnold
Journal:  Br J Pharmacol       Date:  2021-09-30       Impact factor: 9.473

Review 7.  Cannabis for pediatric epilepsy: protocol for a living systematic review.

Authors:  Jesse Elliott; Deirdre DeJean; Tammy Clifford; Doug Coyle; Beth Potter; Becky Skidmore; Christine Alexander; Alexander E Repetski; Bláthnaid McCoy; George A Wells
Journal:  Syst Rev       Date:  2018-07-18

8.  Don't Fear the Reefer-Evidence Mounts for Plant-Based Cannabidiol as Treatment for Epilepsy.

Authors:  M Scott Perry
Journal:  Epilepsy Curr       Date:  2019 Mar-Apr       Impact factor: 7.500

9.  Medicinal cannabis: knowledge, beliefs, and attitudes of Colombian psychiatrists.

Authors:  Juan Manuel Orjuela-Rojas; Xiomara García Orjuela; Sabina Ocampo Serna
Journal:  J Cannabis Res       Date:  2021-07-05

Review 10.  Cannabinoids in the Treatment of Epilepsy: Hard Evidence at Last?

Authors:  Emilio Perucca
Journal:  J Epilepsy Res       Date:  2017-12-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.